Lotus Eye Hospital Q1 Results: Net profit rises 13% YoY to ₹61 lakh
Lotus Eye Hospital posted a 12.6% YoY rise in net profit to ₹61.37 lakh in Q1FY27, driven by a 26.2% surge in revenue to ₹1,705.71 lakh. Pre-tax profits jumped 38.4%, but net profit growth was tempered by higher tax and finance costs. Statutory auditors Anbarasu & Jalapathi completed a limited review of the results approved by the Board on August 10, 2026.

*this image is generated using AI for illustrative purposes only.
Lotus Eye Hospital reported a net profit of ₹61.37 lakh for the quarter ended June 30, 2026, marking a 12.6% increase from ₹54.48 lakh in the corresponding quarter of the previous year. The Coimbatore-based eye care provider saw revenue from operations surge 26.2% to ₹1,705.71 lakh, up from ₹1,351.69 lakh in Q1FY26, signaling strong demand recovery and operational scaling in its single-segment business.
The Board of Directors approved the standalone unaudited financial results at a meeting held on August 10, 2026, pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, Anbarasu & Jalapathi Chartered Accountants, who issued their report on the same day.
Financial Performance
Revenue growth was supported by increased patient footfall and service utilization, though operating expenses also expanded to meet the higher volume. Total income rose to ₹1,726.79 lakh from ₹1,370.45 lakh in Q1FY26. While other income declined slightly to ₹21.08 lakh from ₹18.76 lakh, the core operational revenue drove the overall top-line expansion.
| Metric | Q1FY27 (₹ in lakhs) | Q1FY26 (₹ in lakhs) | Change |
|---|---|---|---|
| Revenue from operations | 1,705.71 | 1,351.69 | +26.2% |
| Total Income | 1,726.79 | 1,370.45 | +26.0% |
| Total Expenses | 1,625.44 | 1,297.74 | +25.2% |
| Profit Before Tax | 101.02 | 72.98 | +38.4% |
| Net Profit | 61.37 | 54.48 | +12.6% |
Profit before tax improved significantly by 38.4% to ₹101.02 lakh, reflecting better cost management relative to revenue growth. However, net profit growth was moderated by higher tax expenses, which stood at ₹39.65 lakh compared to ₹18.50 lakh in the prior year quarter. This included deferred tax expenses of ₹39.65 lakh, impacting the bottom-line retention.
Expense Breakdown
Operational costs scaled with revenue, with employee benefit expenses rising to ₹364.89 lakh from ₹284.38 lakh, and service expenses increasing to ₹324.82 lakh from ₹261.20 lakh. Finance costs more than quadrupled to ₹50.65 lakh from ₹11.76 lakh, likely due to new borrowings or interest rate adjustments, though this was partially offset by lower other expenses at ₹232.38 lakh versus ₹239.85 lakh. Depreciation and amortization expenses also nearly doubled to ₹163.54 lakh, indicating capital expenditure deployment.
What the Numbers Show
The divergence between the 38.4% rise in pre-tax profits and the 12.6% rise in net profit highlights the impact of tax structuring and deferred tax liabilities on final earnings. While operational efficiency improved—evidenced by total expenses growing at a similar pace to revenue—the significant jump in finance costs suggests increased leverage or debt servicing obligations that warrant monitoring in subsequent quarters. The company’s ability to maintain margin stability despite higher interest outlays demonstrates resilient core operations in the eye care segment.
Historical Stock Returns for Lotus Eye Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.55% | +2.90% | +2.19% | +0.60% | +65.06% | +166.53% |
How will the significant increase in finance costs and new borrowings impact Lotus Eye Hospital's debt-to-equity ratio and future interest coverage in upcoming quarters?
What specific expansion projects or capital expenditures drove the near-doubling of depreciation and amortization expenses, and when are these assets expected to yield ROI?
Given the divergence between pre-tax profit growth (38.4%) and net profit growth (12.6%), what strategies is management employing to optimize tax structuring and reduce deferred tax liabilities?


































